Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005525 220002161 null null Palliative (P) null 2017-03-31 Cytarabine Low Dose 02 null 220028391 CYTARABINE
220005526 220002161 1.64 70 Curative (C) 2015-11-05 2015-11-24 AML17 TRIAL N N 220028391 AML17 TRIAL
220005527 220002161 null 104 null 2013-11-24 2013-11-24 CYTARABINE N N 220028391 CYTARABINE
220005528 220002162 1.69 null Palliative (P) null 2015-04-01 Cytarabine Low Dose null null 220028398 CYTARABINE
220005529 220002162 1.52 87.2 Not known (9) 2016-04-06 2016-04-06 AML17 TRIAL 1 N 220028398 AML17 TRIAL
220005530 220002163 1.74 100.9 Curative (C) 2016-04-26 2016-04-26 AML17 TRIAL Y N 220028402 AML17 TRIAL
220005531 220002164 null 123.3 Curative (C) 2017-07-13 2017-07-14 Cytarabine Low Dose null null 220028404 CYTARABINE
220005532 220002164 null null null 2017-10-11 2017-10-12 Cytarabine Low Dose 02 N 220028404 CYTARABINE
220005533 220002164 1.7 87.1 Palliative (P) 2013-03-07 2013-03-07 Cytarabine Low Dose N null 220028404 CYTARABINE
220005537 220002166 1.72 77 Curative (C) 2013-09-30 2013-09-30 AML17 TRIAL 1 N 220028420 AML17 TRIAL
220005539 220015988 1.71 77.8 Curative (C) 2016-06-22 2016-07-11 AML17 TRIAL 1 N 220028429 AML17 TRIAL
220005540 220015988 null 78.9 Disease modification (D) 2014-04-12 2014-04-12 CYTARABINE 2 N 220028429 CYTARABINE
220005541 220015988 1.73 56 Adjuvant (A) 2017-06-14 2017-06-14 Cytarabine Low Dose 02 N 220028429 CYTARABINE
220005542 220002167 null 0 Palliative (P) 2015-11-22 2015-11-24 Cytarabine low (10to20mg/m2) IV/SC N N 220028437 CYTARABINE
220005543 220002168 null 80 Palliative (P) 2017-06-02 2017-06-02 Trial Unspecified Y N 220028439 TRIAL
220005544 220002168 1.56 93 Curative (C) 2015-12-26 2016-01-27 AML17 TRIAL Y N 220028439 AML17 TRIAL
220005545 220002168 0 null Not known (9) 2014-09-02 2014-09-05 AML17 TRIAL N N 220028439 AML17 TRIAL
220005546 220002169 0 null Palliative (P) null 2014-06-23 Cytarabine Low Dose N N 220028448 CYTARABINE
220005547 220002170 1.67 85.5 Curative (C) 2013-09-28 2013-10-01 AML17 TRIAL N N 220028449 AML17 TRIAL
220005548 220011184 1.89 null Curative (C) 2014-10-13 2014-10-13 LI-1 TRIAL Y N 220028450 TRIAL
220005549 220011184 1.65 85.699 Curative (C) 2014-07-12 2014-08-17 AML17 TRIAL Y N 220028450 AML17 TRIAL
220005550 220011184 null 58.8 Adjuvant (A) 2014-03-31 2014-03-31 Cytarabine Low Dose N N 220028450 CYTARABINE
220005551 220002171 1.47 63 Curative (C) 2014-03-09 2014-03-11 AML17 TRIAL Y N 220028456 AML17 TRIAL
220005552 220002171 null 88.6 Curative (C) 2017-01-31 2017-01-31 AML17 TRIAL Y N 220028456 AML17 TRIAL
220005553 220002171 1.61 121 Disease modification (D) 2014-12-05 2014-12-11 Trial Unspecified null N 220028456 TRIAL
220005554 220002171 1.7 76.2 Curative (C) 2014-09-25 2014-09-26 AML17 TRIAL 01 N 220028456 AML17 TRIAL
220005555 220002171 1.64 null Adjuvant (A) 2014-02-21 2014-02-25 Cytarabine Low Dose 2 N 220028456 CYTARABINE
220005556 220002171 1.72 null Curative (C) 2014-08-20 2014-08-21 AML17 TRIAL 02 N 220028456 AML17 TRIAL
220005557 220002172 0 64 Palliative (P) 2013-12-11 2013-12-13 Cytarabine Low Dose N N 220028471 CYTARABINE
220005558 220002172 1.69 118 Adjuvant (A) 2015-09-17 2015-09-17 AML17 TRIAL Y N 220028471 AML17 TRIAL
220005559 220002173 null 119.5 Curative (C) 2015-10-17 2015-10-17 Trial Unspecified 01 N 220028473 TRIAL
220005560 220002174 1.79 57 null 2015-01-21 2015-01-22 AML17 TRIAL 2 Y 220028475 AML17 TRIAL
220005561 220002174 1.73 null null 2013-12-26 2013-12-26 Cytarabine Low Dose null N 220028475 CYTARABINE
220005562 220015992 null 50.9 Palliative (P) 2015-07-12 2015-07-12 Cytarabine Low Dose N N 220028479 CYTARABINE
220005563 220015992 1.66 69.9 Not known (9) null 2014-12-07 AML17 TRIAL null null 220028479 AML17 TRIAL
220005564 220002175 1.64 66.1 Curative (C) 2017-12-03 2017-12-03 AML17 TRIAL N N 220028484 AML17 TRIAL
220005565 220002176 1.31 65 Not known (9) 2015-05-10 2015-05-11 AML17 TRIAL N N 220028486 AML17 TRIAL
220005566 220002176 1.59 68 Palliative (P) 2013-04-24 2013-04-24 Trial Unspecified Y N 220028486 TRIAL
220005567 220002177 1.65 84.3 Curative (C) 2013-08-22 2013-08-23 AML17 TRIAL null null 220028489 AML17 TRIAL
220005568 220002177 1.66 68.5 Curative (C) 2013-05-11 2013-05-11 Trial Unspecified 01 null 220028489 TRIAL
220005569 220015993 1.82 87 Not known (9) 2016-10-13 2016-10-13 Trial Unspecified 1 N 220028491 TRIAL
220005570 220002178 1.63 72.7 Palliative (P) null 2014-11-14 Cytarabine Low Dose 2 N 220028492 CYTARABINE
220005571 220002179 0 79.4 Disease modification (D) 2015-01-28 2015-02-09 Trial Unspecified Y null 220028495 TRIAL
220005572 220011190 null null Palliative (P) 2015-12-14 2015-12-17 Cytarabine low (10to20mg/m2) IV/SC 02 N 220028498 CYTARABINE
220005573 220002180 1.58 null Palliative (P) 2014-06-26 2014-07-01 Cytarabine Low Dose N N 220028499 CYTARABINE
220005574 220002181 null null Palliative (P) 2014-12-12 2014-12-18 Cytarabine low (10to20mg/m2) IV/SC N N 220028500 CYTARABINE
220005575 220002181 1.68 94.3 null 2017-09-16 2017-09-20 Cytarabine Low Dose 2 N 220028500 CYTARABINE
220005576 220002181 1.71 69.4 Palliative (P) 2016-02-29 2016-02-29 Trial Unspecified Y N 220028500 TRIAL
220005577 220002182 1.7 null Curative (C) 2014-10-21 2014-10-22 AML17 TRIAL 1 null 220028504 AML17 TRIAL
220005578 220002182 1.62 75 Palliative (P) 2017-06-25 2017-06-25 Cytarabine Low Dose N N 220028504 CYTARABINE